BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Briolay T, Petithomme T, Fouet M, Nguyen-Pham N, Blanquart C, Boisgerault N. Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Mol Cancer 2021;20:55. [PMID: 33761944 DOI: 10.1186/s12943-021-01346-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zattoni IF, Delabio LC, de Paula Dutra J, Kita DH, Scheiffer G, Hembecker M, da Silva Pereira G, Moure VR, Valdameri G. Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114346] [Reference Citation Analysis]
2 Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol 2021;14:85. [PMID: 34059100 DOI: 10.1186/s13045-021-01096-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ulfo L, Cantelli A, Petrosino A, Costantini PE, Nigro M, Starinieri F, Turrini E, Zadran SK, Zuccheri G, Saporetti R, Di Giosia M, Danielli A, Calvaresi M. Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy. Nanoscale 2021. [PMID: 34792088 DOI: 10.1039/d1nr06053h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Belleri M, Chiodelli P, Corli M, Capra M, Presta M. Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase. Biochim Biophys Acta Rev Cancer 2021;1877:188675. [PMID: 34974112 DOI: 10.1016/j.bbcan.2021.188675] [Reference Citation Analysis]
5 Miao Y, Yang T, Yang S, Yang M, Mao C. Protein nanoparticles directed cancer imaging and therapy. Nano Converg 2022;9:2. [PMID: 34997888 DOI: 10.1186/s40580-021-00293-4] [Reference Citation Analysis]
6 Kang SR, Nguyen DH, Woong Yoo S, Min JJ. Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Adv Drug Deliv Rev 2021;:114085. [PMID: 34933064 DOI: 10.1016/j.addr.2021.114085] [Reference Citation Analysis]
7 Heshmati Aghda N, Dabbaghianamiri M, Tunnell JW, Betancourt T. Design of Smart Nanomedicines for Effective Cancer Treatment. Int J Pharm 2022;:121791. [PMID: 35525473 DOI: 10.1016/j.ijpharm.2022.121791] [Reference Citation Analysis]
8 Lai WH, Fang CY, Chou MC, Lin MC, Shen CH, Chao CN, Jou YC, Chang D, Wang M. Peptide-guided JC polyomavirus-like particles specifically target bladder cancer cells for gene therapy. Sci Rep 2021;11:11889. [PMID: 34088940 DOI: 10.1038/s41598-021-91328-7] [Reference Citation Analysis]
9 Volovat S, Ursulescu CL, Moisii LG, Volovat C, Boboc D, Scripcariu D, Amurariti F, Stefanescu C, Stolniceanu CR, Agop M, Lungulescu C, Volovat CC. The Landscape of Nanovectors for Modulation in Cancer Immunotherapy. Pharmaceutics 2022;14:397. [DOI: 10.3390/pharmaceutics14020397] [Reference Citation Analysis]